Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of immunomodulation with epigenetic therapy
$306,956Nilofer S. Azad · Johns Hopkins University · P01 · FY2023 · CA
ARHI (DIRAS 3) in Autophagy and Dormancy of Ovarian Cancer
$306,953Robert C Bast · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
ARHI (DIRAS 3) in Autophagy and Dormancy of Ovarian Cancer
$306,953Robert C Bast · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Project 2: Biological Effects of Patient-derived Mutations in MUC16 on PC Metastasis
$306,946Michael A Hollingsworth · University Of Nebraska Medical Center · P01 · FY2019 · CA
Project 3: MUC16-Mediated Metabolic Reprograming Induces PC Metastasis
$306,945Pankaj Kumar Singh · University Of Nebraska Medical Center · P01 · FY2019 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$306,943Andrew M Lowy · University Of California, San Diego · R01 · FY2020 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$306,943Andrew M Lowy · University Of California, San Diego · R01 · FY2017 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$306,943Andrew M Lowy · University Of California, San Diego · R01 · FY2018 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$306,943Andrew M Lowy · University Of California, San Diego · R01 · FY2021 · CA
Translation of Evolved Oncolytic Virotherapy Product for Colorectal Cancer Treatment
$306,871Adam J Schieferecke · Vivere Oncotherapies, Inc. · R41 · FY2025 · CA
CD4+ Memory T-Cells in Human Lung Tumor Micorenvironment
$306,865State University Of New York At Buffalo · R01 · FY2005 · CA
How environmental chemicals impair immunity
$306,850Boston University Medical Campus · R01 · FY2004 · ES
How environmental chemicals impair immunity
$306,850Boston University Medical Campus · R01 · FY2005 · ES
T Cell Unresponsiveness in Human Tumors
$306,828James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas
$306,818Samra Turajlic · Francis Crick Institute, Ltd · U01 · FY2022 · CA
Cell mediated immunity in mammary tumor models
$306,788University Of Miami School Of Medicine · R01 · FY2004 · CA
Cell mediated immunity in mammory tumor models
$306,788University Of Miami School Of Medicine · R01 · FY2005 · CA
Mechanisms of immunomodulation with epigenetic therapy
$306,762Nilofer S. Azad · Johns Hopkins University · P01 · FY2022 · CA
Core C: Animal Models
$306,747Stefan Niewiesk · Ohio State University · P01 · FY2017 · CA
Inhibitors of ENPP1 for the treatment of hepatocellular carcinoma
$306,739Deepa Sengupta · Riboscience, Llc · R41 · FY2025 · CA
DNA-specific pattern recognition receptor activation following DNA electroporation
$306,683Loree C Heller · Old Dominion University · R01 · FY2019 · CA
Correction of myeloid cell defects in cancer
$306,680Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2013 · CA
Correction of myeloid cell defects in cancer
$306,680Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2015 · CA
Core C: Cell Biology Core
$306,670Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA
Project 8 - TH17 Dendritic Cell Vaccine
$306,631Keith L Knutson · Mayo Clinic Rochester · P50 · FY2017 · CA